Apoptosis has an essential role in controlling T cell homeostasis, especially during the contraction phase of an immune response. However, its contribution to the balance between effector and regulatory populations remains unclear. We found that Rag1 À/À hosts repopulated with Bim À/À conventional CD4 þ T cells (Tconv) resulted in a larger induced regulatory T cell (iTreg) population than mice given wild-type (WT) Tconv. This appears to be due to an increased survival advantage of iTregs compared with activated Tconv in the absence of Bim. Downregulation of Bcl-2 expression and upregulation of Bim expression were more dramatic in WT iTregs than activated Tconv in the absence of IL-2 in vitro. The iTregs generated following Tconv reconstitution of Rag1 À/À hosts exhibited lower Bcl-2 expression and higher Bim/Bcl-2 ratio than Tconv, which indicates that iTregs were in an apoptosis-prone state in vivo. A significant proportion of the peripheral iTreg pool exhibits low Bcl-2 expression indicating increased sensitivity to apoptosis, which may be a general characteristic of certain Treg subpopulations. In summary, our data suggest that iTregs and Tconv differ in their sensitivity to apoptotic stimuli due to their altered ratio of Bim/Bcl-2 expression. Modulating the apoptosis pathway may provide novel therapeutic approaches to alter the balance between effector T cells and Tregs.
Apoptosis has an essential role in controlling T cell homeostasis, especially during the contraction phase of an immune response. However, its contribution to the balance between effector and regulatory populations remains unclear. We found that Rag1 À/À hosts repopulated with Bim À/À conventional CD4 þ T cells (Tconv) resulted in a larger induced regulatory T cell (iTreg) population than mice given wild-type (WT) Tconv. This appears to be due to an increased survival advantage of iTregs compared with activated Tconv in the absence of Bim. Downregulation of Bcl-2 expression and upregulation of Bim expression were more dramatic in WT iTregs than activated Tconv in the absence of IL-2 in vitro. The iTregs generated following Tconv reconstitution of Rag1 À/À hosts exhibited lower Bcl-2 expression and higher Bim/Bcl-2 ratio than Tconv, which indicates that iTregs were in an apoptosis-prone state in vivo. A significant proportion of the peripheral iTreg pool exhibits low Bcl-2 expression indicating increased sensitivity to apoptosis, which may be a general characteristic of certain Treg subpopulations. In summary, our data suggest that iTregs and Tconv differ in their sensitivity to apoptotic stimuli due to their altered ratio of Bim/Bcl-2 expression. Modulating the apoptosis pathway may provide novel therapeutic approaches to alter the balance between effector T cells and Tregs. þ T cells (Tconv) in the periphery during an immune response. iTregs can be induced in response to either increased expression of selfantigen or as a consequence of infection. Therefore, their homeostasis must be tightly controlled. Insufficient differentiation of iTregs may result in immune pathogenesis, whereas prolonged survival of these cells may compromise the establishment of immune memory. Although significant insight has been obtained concerning Treg development and differentiation, 1 little is known about the molecular mechanism(s) controlling nTreg and iTreg survival. [2] [3] [4] [5] The BH3-only family member Bim (encoded by Bcl2l11) is a pro-apoptotic molecule that controls the coordinated contraction of the immune T cell response. [6] [7] [8] [9] It directly interacts with and deactivates the anti-apoptotic regulators Bcl-2 and Bcl-xl. Thus, the fine balance between Bim and Bcl-2/Bcl-xl expression levels represents an important checkpoint for cell survival. 10, 11 Despite enhanced peripheral T cell expansion, Bim À/À mice do not develop aggressive T cell-mediated autoimmune disease. 12 This may be due in part to an increased Treg population in moderately aged Bim À/À animals compared with their wild-type (WT) littermates. 13, 14 Interestingly, Bim expression naturally declines in peripheral WT CD4 þ T cells during aging, 15 which is co-incident with increasing numbers of Tregs. This raises the possibility that Bim has an important role in Treg homeostasis.
As iTregs and nTregs cannot be distinguished in Bim
animals, the impact that Bim depletion has on either Treg cell subtype remains unclear. It appears that depletion of Bim may have a limited impact on nTreg development, as the emigration rate of nTregs from the thymus is similar in WT and Bim À/À mice. 13 The observation that Bim À/À nTregs are more proliferative is, however, contradictory to the observation that Bim À/À T cells are hypo-responsive upon TCR activation. 16 In this study, we ask if the balance between Bim and Bcl-2 acts as a critical survival parameter that controls iTreg homeostasis.
Results
Preferential induction of iTregs in vivo in the absence of Bim. To directly investigate the influence of Bim depletion on iTreg homeostasis in vivo, we induced inflammatory bowel disease (IBD) in mice by adoptively transferring CD4 þ
CD25
À CD45RB hi Tconv into Rag1 À/À hosts. In this model, transferred Tconv repopulate the host lymphoid tissue, leading to intestinal inflammation in a certain percentage of Tconv recipients. As only Tconv are transferred (Supplementary Figure S1a ), essentially all Foxp3 þ T cells recovered from the recipients are de novo-generated iTregs. Although Bim is important for T-cell apoptosis, we only observed a slight difference between Bim À/À and WT Tconv recipients in both percentage and absolute number of CD4 þ T cells recovered from the spleens and mesenteric lymph nodes (MLN) (Figures 1a and b) . Surprisingly, there was a significant increase in the percentage (B2-3-fold) and number (B3-4-fold) of Foxp3 þ CD4 þ iTregs recovered from Bim À/À Tconv recipients compared with WT Tconv recipients in the spleen, MLN and a combined population of intraepithelial lymphocytes and lamina propria lymphocytes (IEL/LPL) isolated from the intestines (Figures 1c and d (Figure 1f and Supplementary Figure S1b) . This difference, however, was minimal in terms of the number of CD4 Figure S1c) . Interestingly, there was an increased percentage and number of Bim (Figure 1f and Supplementary Figure S1c ). This may partially explain the larger fold difference between the number of Bim À/À iTregs and WT iTregs in the spleen (B3-fold difference) compared with MLN (B2-fold difference).
Consistent with these data, mice that received Bim
À/À
Tconv had an B50% reduction in the incidence of IBD (as measured by weight loss greater than 5% initial body weight) than WT Tconv recipients (P ¼ 7.52 Â 10 À5 ; relative risk ¼ 0.491; 95% CI (0.346-0.700); Figure 1g ). Taken together, these data suggest that the loss of Bim has a preferential effect on the generation and/or survival of iTregs, compared with the proportion of transferred Tconv that do not convert to a Foxp3 þ population, resulting in a protective effect against IBD. Figure S2d) Figure S2e) .
Loss of
The third possibility is that Bim depletion has a differential effect on the survival of iTregs versus Tconv. Constitutive expression of the IL-2 receptor (CD25) is a hallmark for nTregs and it is well known that they are highly dependent on IL-2 for their homeostasis and survival. 18, 19 Given the fact that Bim is a principal component in growth factor deprivation-mediated apoptosis, we compared the survival capacity of WT and Bim À/À iTregs, and activated Tconv in the absence of IL-2. The iTregs were generated by activating purified Tconv from . Foxp3 þ iTregs were more vulnerable to apoptosis than Foxp3 À -activated Tconv over a wide range of limited exogenous IL-2 supplementation (from 10 U/ml to 100 U/ml; Figure 2c ). However, these differences in survival capacity between iTregs and activated Tconv were abrogated in both cell populations in the absence of Bim (Figures 2a and b) . These data suggest that iTregs are more sensitive to IL-2 deprivation-mediated apoptosis than activated Tconv. Loss of Bim expression confers a greater survival advantage for Foxp3 þ iTregs, nullifying their increased sensitivity to growth factor withdrawal.
Intrinsic vulnerability to apoptosis due to altered Bim, Bcl-2 and Bcl-xl balance in iTregs. We next investigated the mechanism responsible for the survival disparity between iTreg and activated Tconv in the presence of limited IL-2. Activated T cells only express IL-2 transiently following TCR engagement. Blocking IL-2 signaling by using an anti-CD25 
. Data are the mean ± S.E. of two independent experiments with four mice per group, and statistical analysis performed using standard unpaired t-test (*Po0.05, **Po0.01). (g) Incidence of IBD in Tconv recipients and statistical summary (2 Â 2 w
-analysis)
Homeostasis of iTregs via Bcl-2/Bim X Wang et al antibody had little effect on activated Tconv survival in the absence of exogenous IL-2 addition. Thus, the survival advantage of activated Tconv over iTregs under limiting IL-2 conditions was likely due to cell intrinsic mechanisms rather than an autocrine IL-2 pathway.
As deletion of the pro-apoptotic molecule Bim was able to mitigate the survival differences between iTregs and activated Tconv, we compared the expression levels of several pro-and anti-apoptotic Bcl-2 family members in iTregs and activated Tconv before (pre) and after (post) a 2-day culture in the absence of exogenous IL-2 ( Figure 3a) . The expression of the pro-apoptotic members of the Bcl-2 family, Bim and Bax, was increased to a similar extent in iTregs and activated Tconv (change between expression pre-and post-IL-2 removal). No change in Bid expression level was observed. Expression of the anti-apoptotic molecules Bcl-2 and Bcl-xl was slightly higher in iTregs compared with activated Tconv before IL-2 withdrawal (Figure 3a ; noted as 'pre'). However, culturing cells in the absence of exogenous IL-2 for just 48 h resulted in a much more dramatic decrease of Bcl-2 expression in iTregs compared with activated Tconv, which was accompanied with a larger increase of Bim expression (Figure 3a ; noted as 'post'). Similar but less pronounced changes were observed with Bcl-xl and Bax. Mcl-1 and Noxa have recently been shown to be important in regulating T-cell apoptosis during clonal expansion. 20 Despite substantial upregulation of Noxa following T-cell activation, there was no difference in the relative expression of Mcl-1 and Noxa mRNA between Tconv and iTregs (Supplementary Figure S3) .
As cell survival is dependent on the balance between pro-and anti-apoptotic molecules rather than their absolute expression levels, analysis of the relative ratios of interactive partners may be an informative parameter to elucidate cellular sensitivity to apoptosis. Minimal differences in the Bim/Bcl-2, Bim/Bcl-xl, Bax/Bcl-2 and Bax/Bcl-xl expression ratios were observed between freshly sorted iTregs and activated Tconv (Figure 3b ; pre), suggesting that their initial sensitivity to apoptosis may be similar. However, continued culture in the absence of IL-2 resulted in a significant increase in the Bim/ Bcl-2 expression ratio in iTregs (B7-fold -pre versus post) versus activated Tconv (B3-fold). There was also an B3-fold increase in the Bim/Bcl-xl ratio in iTregs, which was not observed with activated Tconv (Figure 3b ). Similar changes were observed with the Bax/Bcl-2 or Bax/Bcl-xl ratios. As anticipated, IL-2 supplementation prevented the increase of Bim/Bcl-2 ratio, which correlated with their capacity to promote iTreg survival to a level comparable to activated Tconv (Supplementary Figure S4) . Consistent with this mRNA analysis, we observed a much larger proportion of iTregs that lost intracellular Bcl-2 protein expression following IL-2 withdrawal, compared with activated Tconv (Figure 3c) . Collectively, these data suggest that iTregs are intrinsically less capable of maintaining an appropriate balance between the pro-(Bim/Bax) and anti-(Bcl-2/Bcl-xl) apoptotic proteins to ensure survival.
Reduced Bcl-2 expression in iTregs in vivo. To extend our findings in vivo, we transferred the Foxp3 GFP Tconv or CD4 þ CD25 À CD45RB hi Tconv from WT mice into Rag1 À/À recipients and analyzed the expression levels of the Bcl-2 family molecules in iTregs and Tconv recovered 4 weeks post-transfer. Although expression levels of Bim, Bcl-xl and Bax were fairly comparable between iTreg and Tconv, iTregs consistently expressed four to five times less Bcl-2 than Tconv recovered from the spleen (Figure 4a) . Consequently, the Bim/Bcl-2 and Bax/Bcl-2 mRNA ratios were substantially (Figures 4b and c) . No difference in Bax/Bcl-xl ratio was observed (Figure 4c) . Interestingly, Bcl-2 mRNA expression in iTregs and Tconv recovered from the MLN was similar, which mirrored our observation that there was a somewhat less profound increase in the number of iTregs in MLN versus the spleen in the absence of Bim (Figures 1c and d) . Given that the MLN serves as the primary site of immune response in the IBD model, it is possible that the levels of growth factors such as IL-2 are more abundant here compared with more distal lymphoid tissues such as the spleen.
Intracellular Bcl-2 protein staining confirmed that iTregs consistently express less Bcl-2 (B3-fold) compared with Foxp3 À Tconv isolated from the spleen, non-draining lymph nodes, MLN and IEL/LPL of repopulated Rag1 À/À hosts (Figures 4d and e) . This was also observed with cells isolated from Rag1
À/À hosts repopulated with Bim À/À Tconv (Figure 4e ). Bcl-2 expression in iTregs was also consistently higher in the MLN. Collectively, iTregs seem to have a deficiency in Bcl-2 expression, which may render them more susceptible to apoptosis in vivo.
Foxp3
þ Bcl2 lo Treg populations in vivo. The nTregs are reported to express higher levels Bcl-2 than Tconv. 21 15, 16 Our data suggest that decreased Bim expression confers a preferential survival advantage on iTregs. Therefore, depletion or downregulation of Bim limits the rapid peripheral Treg cell turnover, 25 which consequently results in increased Treg numbers. As optimal TCR signaling is required for iTreg differentiation, and the T-cell population with the highest proliferative capacity tends to differentiate into iTregs more efficiently, higher BrdU incorporation in the Foxp3 þ Bim lo T-cell population may represent enhanced iTreg survival due to lower Bim expression in vivo rather than nTreg expansion. In line with our model, overexpression of the anti-apoptotic molecule Bcl-2 in T cells also results in an increased proportion of iTregs in vivo and reduces the incidence of autoimmune disease. 26 The importance of IL-2 in the development and homeostatic maintenance of nTregs, iTreg and Tconv is well documented. 18, 19, 27 IL-2-or IL-2R-deficient mice have a two-fold reduction in the number of Tregs and suffer from a severe lymphoproliferative disease. 2, 28 However, crossing IL-2-or IL-2R-deficient mice with Bim À/À mice eliminated this numerical deficiency, supporting our data that demonstrates the level of vBim expression is important for iTreg survival. 28 Nevertheless, restoration of Foxp3
mice did not prevent the lymphoproliferative disease unless exogenous IL-2 was added, suggesting that IL-2 is also required for the function of Tregs in vivo. 28 It has been reported that IL-2 and signaling through the IL-2R regulates Bcl-2 expression. 29 Our data supports this observation as IL-2 deprivation resulted in a significant decrease in both Bcl-2 and Bcl-xl expression in vitro. Taken together, this strongly suggests an IL-2-dependent link between Bim and Bcl-2 levels, and supports our conclusion that in the absence of Bim, there is increased survival of iTregs and consequently a higher number of Tregs. How this relates to a decrease in IBD incidence may be two-fold. First, in the absence of Bim, there may be a reduction in apoptosis resulting in more iTregs. À/À -120 : 1), which may increase the probability that Bim-deficient iTregs outcompete Tconv for the available IL-2 that is required for optimal Treg suppression in vivo. 28 Although the notion that different T-cell subpopulations may preferentially use different pro-and anti-apoptotic pathways to regulate homeostasis has been previously proposed, 30 no clear examples have been documented. Our data suggest that balanced expression within the Bim/Bcl-2 axis has a greater impact on the survival of iTregs than activated Tconv in vitro and in vivo. It is possible that lineage-specific transcription factors may preferentially modulate the expression of specific Bcl-2 family apoptotic modulator(s). A previous ChIP-ChIP study revealed that Foxp3 is constitutively bound to the Bcl-2 locus, but not any other Bcl-2 family members. 31 It remains unclear whether such binding promotes or represses Bcl-2 expression. Although depletion of the Foxp3-recruited transcriptional repressor Eos results in increased Bcl-2 expression, iTregs themselves express more Bcl-2 than activated Tconv. 21 A more intriguing hypothesis is that Foxp3 may modulate Bcl-2 expression in a conditional manner. By recruiting different nuclear factors, Foxp3 may promote Bcl-2 expression when IL-2 is in excess, but repress Bcl-2 expression when IL-2 is limited. This may be particularly relevant in specific diseases such as autoimmune diabetes, in which defective IL-2 production has been documented. 32 If Foxp3 is directly modulating Bcl-2 expression in Tregs, it is unclear whether nTregs, like iTregs, are also hypersensitive to apoptosis.
A decreased Treg/Tconv cell ratio has been implicated in the onset of autoimmune diabetes. 32 Indeed, consistent with our finding that iTregs have a greater apoptotic tendency in vitro and in vivo, profound Treg apoptosis has been shown to occur during diabetes onset. 32 Interestingly, our study suggests that there may be two subpopulations of Tregs expressing different levels of Bcl-2, and it is the Bcl-2 hi population that is preferentially lost during progression towards diabetes. The majority of the detectable Tregs in islets are phenotypically CD4 þ Foxp3 þ Bcl-2 lo Ki67 þ , which may represent newly differentiated iTregs at the site of inflammation. In summary, the balance between Tregs and Tconv has a central role in maintaining immune tolerance and promoting immune response. Perturbation of the Bim/Bcl-2 balance may represent a new therapeutic approach to modulate the immune environment under diverse disease conditions. Modulation of Bcl-2 expression could be used as an approach to promote survival of iTregs generated for therapeutic application.
Materials and Methods
Mice, T-cell preparation and antibodies. C57BL/6 (WT) and Rag1 À/À mice were obtained from The Jackson Laboratory (Bar Harbor, ME, USA). The Bim À/À mice were provided by Andreas Strasser (The Walter and Eliza Hall Institute of Medical Research, Parkville, Victoria, Australia). 12 The Bim À/À mice were crossed with Foxp3 GFP reporter mice 2 to generate Bim À/À Foxp3 GFP mice. All mice were bred and maintained at St. Jude Children's Research Hospital. All animal experiments were performed in the American Association for the Accreditation of Laboratory Animal Care-accredited, specific pathogen-, Helicobacter-and MNVfree facilities, following national, state and institutional guidelines. Animal protocols were approved by the St. Jude Animal Care and Use Committee.
For IEL/LPL purification, intestines were removed, cut into 0.5 cm pieces and shaken at 371C for 20 min in 45 ml HBSS with 1 mM DTT. Suspension was decanted and filtered through a 70 mm cell strainer into a 50 ml conical tube, and tissue was pelleted by centrifugation for 5 min at 1200 r.p.m. Supernatant was discarded and pellet was reserved on ice. This process was repeated two more times with the strained tissue, pelleting the suspension in the same 50 ml conical tube. The remaining intestinal tissue was finely chopped and incubated in 25 ml RPMI supplemented with 10% FBS and 8000 U of Collagenase Type IV (Worthington Biochemical, Lakewood, NJ, USA), rotating at 371C. Cell suspension was strained and pooled with the previous pelleted collection, centrifuged and supernatant discarded. This was repeated with the strained intestinal tissue. The final cell pellet was washed in RPMI/10% FBS, centrifuged and supernatant discarded. The cell pellet was resuspended in 4 ml of 40 Â percoll (4.0 ml of 100 Â percoll þ 6.0 ml RPMI/10% FBS; GE Healthcare, Piscataway, NJ, USA) and strained through a 70 mm cell strainer. Cell suspension was gently layered over 5.0 ml of 100 Â percoll in a 15 ml conical tube and centrifuged at 2500 r.p.m. with no brake for 20 min at room temperature. Media overlying the band of IEL/LPL at the interface between the two percoll layers was carefully removed. The band of cells was transferred by pipette to a new 15 ml conical tube to which RPMI/10% FBS was added to a final volume of 10 ml. The tube was shaken and centrifuged 10 min at 1500 r.p.m. to pellet the cells. For Tconv and Treg preparation, spleens and lymph nodes from mice were processed and stained with fluorochrome-conjugated antibodies and purified by single-cell sorting using anti-CD4 (clone GK 1.5), anti-CD25 (clone PC61) and anti-CD45RB (clone C363-16A). Tconv used in this study were defined as
, or if the Foxp3 GFP reporter mice were used, CD4 þ GFP À . All antibodies used were from Biolegend (San Diego, CA, USA) or eBiosciences (San Diego, CA, USA). Bcl-2 expression was determined using clone 10C4, and staining performed with Foxp3 fixation/permeablization reagents from eBioscience.
IBD model. Induction of IBD was performed as described previously. 33 Tconv were sorted and plated in 96-well round-bottom plates (1 Â 10 5 per well) with anti-CD3/CD28-coated M-450 tosylactivated dynabeads (Invitrogen, Grand Island, NY, USA) at a ratio of 2.5 cells per bead. After 72 h stimulation, supernatants were collected and analyzed by ELISA. Supernatants were incubated on plates precoated with 1 mg/ml purified anti-IL2 (clone JES6-1A12, Biolegend) for 2 h at room temperature. Then, IL-2 was detected with 1 mg/ml biotinylated anti-IL-2 (clone JES6-5H4 biotin, Biolegend), followed by streptavidin-HRP (Jackson Immunoresearch Laboratories Inc., West Grove, PA, USA) and developed with TMB substrate (Thermo Fisher Scientific, Pittsburgh, PA, USA).
For intracellular staining, spleen and MLN of Rag1 À/À that had received WT or Bim À/À Tconv 4 weeks prior were processed, and the cells were stimulated for 12 h with PMA/ionomycin (100 ng/ml and 500 ng/ml, respectively) in the presence of Brefeldin A (1 : 1000, Biolegend). Following stimulation, cells were stained for surface CD4 and CD25, fixed and stained with antibodies to IL-2 (clone JES5-5H4) or an IgG isotype control, using Cytofix/Cytoperm kit following the manufacturer's instruction (BD Biosciences, San Diego, CA, USA), and analyzed by flow cytometry.
Intracellular staining for Bcl-2 and Foxp3. Purified Tconv (CD4 þ   CD45RB hi CD25 À ) were injected i.v. via the tail vein into Rag1 À/À mice. After 4 weeks, spleen and MLN were processed and cells were stained for surface CD4, and then fixed, permeabilized and stained with antibodies to Bcl2 (clone BCL/10C4), Foxp3 (clone 150D) and an IgG1 isotype control, using the Foxp3 Fixation/ Permeabilization buffer set from EBiosciences according to manufacturer's instructions, and analyzed by flow cytometry.
BrdU analysis. Purified Tconv were injected via the tail vein into Rag1 À/À mice. At 4 weeks post-transfer, mice were injected i.p. with 200 ml of BrdU (10 mg/ml) in PBS. After 16 h, cells from spleen and MLN were harvested, stained for CD4, Foxp3 and BrdU, using the BrdU-APC flow kit (BD Biosciences) following manufacturer's instructions, and analyzed by flow cytometry.
Induced regulatory T-cell differentiation and survival analysis. Tconv were isolated from WT or Bim À/À Foxp3 GFP reporter mice and activated with either plate-bound anti-CD3 (clone 2C11) and soluble anti-CD28 (clone 37.51) or pre-coated CD3/CD28 beads in the presence of 5 ng/ml TGF-b and 100 U/ml IL-2 for 3 days. GFP þ iTreg and activated GFP À Tconv were sorted by FACS. Either cell type was then cultured with or without exogenous IL-2 at a cell density of 5 Â 10 4 per well in 96-well round-bottom plates for the times indicated. Samples were collected and stained with eFluor-670 (eBiosciences), AnnexinV (BD Biosciences) and PI (Sigma-Aldrich, St. Louis, MO, USA). Live cells were defined as AnnexinV Statistics. Data were analyzed using paired, unpaired t-test or Mann-Whitney test, depending upon the data set, and is described in the figure legends. For analysis of disease incidence in Figure 1f , a 2 Â 2 w 2 -analysis was used. P-values were categorized into three levels: *Po0.05, **Po0.01 and ***Po0.005, unless stated otherwise.
